|
2024 Journal Article Kidney hyperfiltration and mitochondrial changes are associated with eGFR decline in young people with type 1 diabetesPham, Uyen N., Pryke, Alison, Baskerville, Tracey, Griffin, Alison, Whiddett, Rani O., Fotheringham, Amelia K., Sullivan, Mitchell A., Nisbet, Janelle, Phillips, Liza, Francis, Ross S., Davis, Elizabeth, Jones, Timothy W., Cameron, Fergus, Couper, Jennifer, Benitez-Aguirre, Paul, Craig, Maria, Johnson, David W., Dalton, R. Neil, Marcovecchio, M. Loredana, Cotterill, Andrew, Barrett, Helen L., Donaghue, Kim C. and Forbes, Josephine M. (2024). Kidney hyperfiltration and mitochondrial changes are associated with eGFR decline in young people with type 1 diabetes. The Journal of Clinical Endocrinology and Metabolism. doi: 10.1210/clinem/dgae787 |
|
2024 Journal Article Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitisSajiir, Haressh, Keshvari, Sahar, Wong, Kuan Yau, Borg, Danielle J., Steyn, Frederik J., Fercher, Christian, Taylor, Karin, Taylor, Breten, Barnard, Ross T., Müller, Alexandra, Moniruzzaman, Md, Miller, Gregory, Wang, Ran, Fotheringham, Amelia, Schreiber, Veronika, Sheng, Yong Hua, Hancock, Janelle Louise, Loo, Dorothy, Burr, Lucy, Huynh, Tony, Lockett, Jack, Ramm, Grant A., Macdonald, Graeme A., Prins, Johannes B., McGuckin, Michael A. and Hasnain, Sumaira Z. (2024). Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis. Nature Communications, 15 (1) 4528, 1-13. doi: 10.1038/s41467-024-48317-x |
|
2023 Conference Publication Targeted interleukin-22 therapy improves glycemic control, steatohepatitis, and fibrosis in experimental models of metabolic dysfunction-associated steatohepatitisSajiir, H., Keshvari, S., Wong, K. Y., Borg, D., Mueller, A., Moniruzzaman, M., Wang, R., Fotheringham, A., Schreiber, V., Sheng, Y., Lockett, J., Ramm, G., Macdonald, G., Prins, J. B., Mcguckin, M. A. and Hasnain, S. Z. (2023). Targeted interleukin-22 therapy improves glycemic control, steatohepatitis, and fibrosis in experimental models of metabolic dysfunction-associated steatohepatitis. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2023, Brisbane, QLD, Australia, 2-5 September 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.16288 |
|
2023 Conference Publication Redox Modulating Small Molecule Improves Diabetic Kidney Disease In The DB/DB Model Of Type 2 DiabetesFotheringham, Amelia, Masagos, Hakeem, Whiddett, Rani, McCarthy, Domenica, Chandrashekar, Preeti, Buckle, Irina, Tse, Brian, Sokolowski, Kamil, Sullivan, Mitchell and Forbes, Josephine (2023). Redox Modulating Small Molecule Improves Diabetic Kidney Disease In The DB/DB Model Of Type 2 Diabetes. 58th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Christchurch, New Zealand, 4–6 September 2023. Richmond, VIC Australia: John Wiley & Sons. |
|
2023 Conference Publication Youth with type 1 diabetes at higher risk of developing diabetic kidney disease have alterations in their urine and plasma metabolomic and mitochondrial dna profilesSullivan, Mitchell, Pham, Uyen, McCarthy, Domenica, Flemming, Nicole, Fotheringham, Amelia, Chandrashekar, Preeti, Whiddett, Rani, Buckle, Irina, Summers, Kim, Hodson, Mark, de Silva, Neisha, Nisbet, Janelle, Morton, Adam, Teasedale, Stephanie, Doomun, Sheik, de Souza, David, Isbel, Nicole, Jones, Timothy, Couper, Jennifer, Coughlan, Melinda, Johnson, David, O'Moore-Sullivan, Trisha, Barret, Helen, Marcovecchio, M. Loredana, Donaghue, Kim and Forbes, Josephine (2023). Youth with type 1 diabetes at higher risk of developing diabetic kidney disease have alterations in their urine and plasma metabolomic and mitochondrial dna profiles. 58th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Christchurch, New Zealand, 4-6 September 2023. Richmond, VIC Australia: John Wiley & Sons. |
|
2022 Journal Article Advanced glycation end products and inflammation in type 1 diabetes developmentDu, Chenping, Whiddett, Rani O., Buckle, Irina, Chen, Chen, Forbes, Josephine M. and Fotheringham, Amelia K. (2022). Advanced glycation end products and inflammation in type 1 diabetes development. Cells, 11 (21) 3503, 1-18. doi: 10.3390/cells11213503 |
|
2022 Conference Publication Mitochondrial dysfunction aligns with risk for diabetic kidney disease in youth with type 1 diabetesSullivan, Mitchell, McCarthy, Domenica, Flemming, Nicole, Chandrashekar, Preeti, Hodson, Mark, Fotheringham, Amelia, Whiddett, Rani, De Silva, Neisha, Nisbet, Jinelle, Morton, Adam, Teasdale, Stephanie, Isbel, Nicole, Jones, Timothy, Couper, Jennier, Thorburn, David, Johnson, David, Cotterill, Andrew, Barrett, Helen, O'Moore-Sullivan, Trisha, Donaghue, Kim and Forbes, Josephine (2022). Mitochondrial dysfunction aligns with risk for diabetic kidney disease in youth with type 1 diabetes. 57th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Sydney, NSW, Australia, 17–19 October 2022. Richmond, VIC, Australia: John Wiley & Sons. |
|
2022 Journal Article Advanced glycation end products (AGEs) and chronic kidney disease: does the modern diet AGE the kidney?Fotheringham, Amelia K., Gallo, Linda A., Borg, Danielle J. and Forbes, Josephine M. (2022). Advanced glycation end products (AGEs) and chronic kidney disease: does the modern diet AGE the kidney?. Nutrients, 14 (13) 2675, 1-28. doi: 10.3390/nu14132675 |
|
2022 Journal Article Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T CellsLeung, Sherman S., Borg, Danielle J., McCarthy, Domenica A., Boursalian, Tamar E., Cracraft, Justen, Zhuang, Aowen, Fotheringham, Amelia K., Flemming, Nicole, Watkins, Thomas, Miles, John J., Groop, Per-Henrik, Scheijen, Jean L., Schalkwijk, Casper G., Steptoe, Raymond J., Radford, Kristen J., Knip, Mikael and Forbes, Josephine M. (2022). Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells. Diabetes, 71 (9), 1994-2008. doi: 10.2337/db22-0177 |
|
2021 Journal Article Kidney disease risk factors do not explain impacts of low dietary protein on kidney function and structureFotheringham, Amelia K., Solon-Biet, Samantha M., Bielefeldt-Ohmann, Helle, McCarthy, Domenica A., McMahon, Aisling C., Ruohonen, Kari, Li, Isaac, Sullivan, Mitchell A., Whiddett, Rani O., Borg, Danielle J., Cogger, Victoria C., Ballard, William O., Turner, Nigel, Melvin, Richard G., Raubenheimer, David, Le Couteur, David G., Simpson, Stephen J. and Forbes, Josephine M. (2021). Kidney disease risk factors do not explain impacts of low dietary protein on kidney function and structure. iScience, 24 (11) 103308, 103308. doi: 10.1016/j.isci.2021.103308 |
|
2021 Journal Article Adherence to dietary and physical activity guidelines in Australian undergraduate biomedical students and associations with body composition and metabolic health: a cross-sectional studyGallo, Linda A., Gallo, Tania F., Young, Sophia L., Fotheringham, Amelia K., Barclay, Johanna L., Walker, Jacqueline L., Moritz, Karen M. and Akison, Lisa K. (2021). Adherence to dietary and physical activity guidelines in Australian undergraduate biomedical students and associations with body composition and metabolic health: a cross-sectional study. Nutrients, 13 (10) 3500, 3500. doi: 10.3390/nu13103500 |
|
2021 Journal Article T cell expression and release of kidney injury molecule-1 in response to glucose variations initiates kidney injury in early diabetesForbes, Josephine M., McCarthy, Domenica A., Kassianos, Andrew J., Baskerville, Tracey, Fotheringham, Amelia J., Giuliani, Kurt T. K., Grivei, Anca, Murphy, Andrew J., Flynn, Michelle C., Sullivan, Mitchell A., Chandrashekar, Preeti, Whiddett, Rani, Radford, Kristen J., Flemming, Nicole, Beard, Sam S., D’Silva, Neisha, Nisbet, Janelle, Morton, Adam, Teasdale, Stephanie, Russell, Anthony, Isbel, Nicole, Jones, Timothy, Couper, Jennifer, Healy, Helen, Harris, Mark, Donaghue, Kim, Johnson, David W., Cotterill, Andrew, Barrett, Helen L. and O’Moore-Sullivan, Trisha (2021). T cell expression and release of kidney injury molecule-1 in response to glucose variations initiates kidney injury in early diabetes. Diabetes, 70 (8), 1754-1766. doi: 10.2337/db20-1081 |
|
2021 Journal Article Short duration alagebrium chloride therapy prediabetes does not inhibit progression to autoimmune diabetes in an experimental modelBorg, Danielle J., Faridi, Pouya, Giam, Kai Lin, Reeves, Peta, Fotheringham, Amelia K., McCarthy, Domenica A., Leung, Sherman, Ward, Micheal S., Harcourt, Brooke E., Ayala, Rochelle, Scheijen, Jean L., Briskey, David, Dudek, Nadine L., Schalkwijk, Casper G., Steptoe, Raymond, Purcell, Anthony W. and Forbes, Josephine M. (2021). Short duration alagebrium chloride therapy prediabetes does not inhibit progression to autoimmune diabetes in an experimental model. Metabolites, 11 (7) 426, 1-21. doi: 10.3390/metabo11070426 |
|
2021 Journal Article Advanced glycation end products as predictors of renal function in youth with type 1 diabetesForbes, Josephine M., Le Bagge, Selena, Righi, Samuel, Fotheringham, Amelia K., Gallo, Linda A., McCarthy, Domenica A., Leung, Sherman, Baskerville, Tracey, Nisbett, Janelle, Morton, Adam, Teasdale, Stephanie, D'Silva, Neisha, Barrett, Helen, Jones, Timothy, Couper, Jennifer, Donaghue, Kim, Isbel, Nicole, Johnson, David W., Donnellan, Leigh, Deo, Permal, Akison, Lisa K., Moritz, Karen M. and O'Moore-Sullivan, Trisha (2021). Advanced glycation end products as predictors of renal function in youth with type 1 diabetes. Scientific Reports, 11 (1) 9422, 9422. doi: 10.1038/s41598-021-88786-4 |
|
2021 Journal Article The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition)Zhuang, Aowen, Yap, Felicia Y. T., Borg, Danielle J., McCarthy, Domenica, Fotheringham, Amelia, Leung, Sherman, Penfold, Sally A., Sourris, Karly C., Coughlan, Melinda T., Schulz, Benjamin L. and Forbes, Josephine M. (2021). The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition). Endocrinology, Diabetes and Metabolism, 4 (3) e00278, e00278. doi: 10.1002/edm2.278 |
|
2020 Journal Article Circulating levels of the soluble receptor for AGE (sRAGE) during escalating oral glucose dosages and corresponding isoglycaemic i.v. glucose infusions in individuals with and without type 2 diabetesFotheringham, Amelia K., Bagger, Jonatan I., Borg, Danielle J., McCarthy, Domenica A., Holst, Jens J., Vilsbøll, Tina, Knop, Filip K. and Forbes, Josephine M. (2020). Circulating levels of the soluble receptor for AGE (sRAGE) during escalating oral glucose dosages and corresponding isoglycaemic i.v. glucose infusions in individuals with and without type 2 diabetes. Nutrients, 12 (10) 2928, 2928-12. doi: 10.3390/nu12102928 |
|
2020 Journal Article Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetesLe Bagge, Selena, Fotheringham, Amelia K., Leung, Sherman S. and Forbes, Josephine M. (2020). Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes. Medicinal Research Reviews, 40 (4) med.21654, 1200-1219. doi: 10.1002/med.21654 |
|
2020 Other Outputs Novel dietary factors in diabetic and non-diabetic kidney diseaseFotheringham, Amelia Katherine (2020). Novel dietary factors in diabetic and non-diabetic kidney disease. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/uql.2020.117 |
|
2019 Other Outputs Novel dietary factors in diabetic and non-diabetic kidney diseaseFotheringham, Amelia (2019). Novel dietary factors in diabetic and non-diabetic kidney disease. PhD Thesis, Faculty of Medicine, The University of Queensland. |
|
2019 Other Outputs Novel dietary factors in diabetic and non-diabetic kidney diseaseFotheringham, Amelia (2019). Novel dietary factors in diabetic and non-diabetic kidney disease. PhD Thesis, School of Biomedical Sciences and School of Psychology, The University of Queensland. |
